Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alcaftadine/ketorolac - Ajanta Pharma

Next Previous
Search
Drug Profile

Alcaftadine/ketorolac - Ajanta Pharma

Alternative Names: Alcaftadine/ketorolac tromethamine - Ajanta Pharma; Ketorolac tromethamine/alcaftadine - Ajanta Pharma; Ketorolac/alcaftadine - Ajanta Pharma

Latest Information Update: 23 Feb 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Ajanta Pharma
  • Class 2 ring heterocyclic compounds; Anti-inflammatories; Antiallergics; Benzazepines; Carboxylic acids; Imidazoles; Non-opioid analgesics; Nonsteroidal anti-inflammatories; Piperidines; Pyrroles; Small molecules
  • Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors; Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Allergic conjunctivitis

Most Recent Events

  • 23 Feb 2022 Launched for Allergic conjunctivitis in India (Ophthalmic)
  • 23 Feb 2022 Registered for Allergic conjunctivitis in India (Ophthalmic)
  • 26 Mar 2019 Ajanta pharma completes a phase III trial in Allergic conjunctivities in India (Ophthalmic) (CTRI2018-09-015810)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top